Summary
NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms underlying a disorder or an intervention response. As part of NIMHs Clinical Trial Pipeline, this NOFO encourages early stage testing of pharmacologic interventions with novel mechanisms of actions or device-based interventions. More specifically, this NOFO is intended to support early stage testing of pharmacologic or device-based interventions using a protocol design where the presumed mechanism of action of the intervention is adequately tested, to provide meaningful information where target modulation yields a dose-dependent neurophysiological/clinical/behavioral effect.
Eligibility
- State Governments
- For Profit Organizations Other Than Small Businesses
- Special District Governments
- County Governments
- Other
- Native American Tribal Governments Federally Recognized
- Public and Indian Housing Authorities
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- Private Institutions of Higher Education
- Small Businesses
- City Or Township Governments
- Public and State Institutions of Higher Education
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- Independent School Districts
- Nonprofits Non Higher Education Without 501c3
Funding categories
- Health
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record